Observational studyEuropean heart journal. Cardiovascular pharmacotherapy2025

Apixaban outcomes in atrial fibrillation patients with a single-dose reduction criterion: ASPIRE 1-year results.

So-Ryoung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.